*DAS (Disease Activity Score) 28 for RA, SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) for SLE and mean AVS (AVS: Analogic Visual Scale) of subjective sicca syndrome, asthenia and pain

NIAID Data Ecosystem40

Escalating-dose peptide immunotherapy induces progressive immunoregulatory changes in self-reactive T cells

神经免疫疾病治疗

T细胞免疫调节

Peptide immunotherapy aims to specifically restore tolerance to the administered self-antigen and prevent autoimmunity without the perturbation of normal immune function. We have developed a dose esca

NIAID Data Ecosystem30

Immune response evaluation in patients treated with TNF-alpha blockade (anti-TNF)

免疫疗法评估

神经免疫疾病治疗

A systematic study of human immune function with the goal of identifying defective mechanisms of immune response in patients treated with TNF-alpha blockade (anti-TNF)

DataCite Commons2022-12-21 更新60

Dataset from A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab in Subjects With Relapsing-Remitting Multiple Sclerosis

多发性硬化药物临床试验

神经免疫疾病治疗

The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped t

NIAID Data Ecosystem30

Characteristics for the rituximab and placebo groups.

资源简介：

相关数据集